Frederick Finnegan
Keine laufenden Positionen mehr
Profil
Frederick Finnegan, former Senior Director-Worldwide New Products at Merck & Co., Inc., former Senior Vice President-Sales & Marketing at Critical Therapeutics, Inc., former Executive Vice President at inVentiv Health, Inc., former Senior Vice President-Specialty Pharmaceuticals at Glenmark Therapeutics Inc., USA, and former Senior Vice President-Program Management at rEVO Biologics, Inc. In 2018-2022, he served as the Chief Business Officer at SAB Biotherapeutics, Inc. Mr. Finnegan holds a graduate degree from the Massachusetts Institute of Technology and an undergraduate degree from the University of New Hampshire.
Ehemalige bekannte Positionen von Frederick Finnegan
| Unternehmen | Position | Ende |
|---|---|---|
| SAB BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01.06.2022 |
| Critical Therapeutics, Inc. | Vertrieb & Marketing | 30.06.2006 |
| REVO BIOLOGICS INC | Corporate Officer/Principal | - |
Glenmark Therapeutics Inc., USA
 Glenmark Therapeutics Inc., USA Pharmaceuticals: MajorHealth Technology Glenmark Therapeutics Inc., USA engages in building a franchise of branded products for Glenmark Pharmaceuticals. The company is headquartered in Mahwah, NJ. | Corporate Officer/Principal | - |
inVentiv Health, Inc.
 inVentiv Health, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health, Inc. provides outsourced product development and commercialization services. It operates its business through the following segments: Clinical and Commercial. The Clinical segment clinical offers a continuum of services spanning phases I-IV of clinical development to the changing needs of pharmaceutical, biotechnology, diagnostic and medical device clients. The Commercial segment consists of selling solution services, communications, patient outcomes and consulting service offerings. The company was founded in 1999 and is headquartered in Burlington, MA. | Corporate Officer/Principal | - |
Ausbildung von Frederick Finnegan
| Massachusetts Institute of Technology | Graduate Degree |
| University of New Hampshire | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| SAB BIOTHERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
| Critical Therapeutics, Inc. | Health Technology |
inVentiv Health, Inc.
inVentiv Health, Inc. Miscellaneous Commercial ServicesCommercial Services inVentiv Health, Inc. provides outsourced product development and commercialization services. It operates its business through the following segments: Clinical and Commercial. The Clinical segment clinical offers a continuum of services spanning phases I-IV of clinical development to the changing needs of pharmaceutical, biotechnology, diagnostic and medical device clients. The Commercial segment consists of selling solution services, communications, patient outcomes and consulting service offerings. The company was founded in 1999 and is headquartered in Burlington, MA. | Commercial Services |
Glenmark Therapeutics Inc., USA
Glenmark Therapeutics Inc., USA Pharmaceuticals: MajorHealth Technology Glenmark Therapeutics Inc., USA engages in building a franchise of branded products for Glenmark Pharmaceuticals. The company is headquartered in Mahwah, NJ. | Health Technology |
rEVO Biologics, Inc.
 rEVO Biologics, Inc. BiotechnologyHealth Technology rEVO Biologics, Inc. engages in the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. Its products include ATryn, which prevents blood clots during and after surgery and childbirth for patients with hereditary antithrombin deficiency. The company was founded in February 1993 and is headquartered in Framingham, MA. | Health Technology |
